24
total announcements
BAJAJHCARE.NS · 15 min delayed
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about the dispatch of Notice of 33rd Annual General Meeting & Annual Report for the financial year 2025-26 and E-Voting Information published in two newspapers.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange regarding the Inland Letters sent to Shareholders, providing the web-link to access the Annual Report 2025-26 to those Shareholders who have not registered their e-mail addresses with the Company or their Depository Participants (DPs).
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange regarding Business Responsibility and Sustainability Report for the financial year 2025-26.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 21, 2026.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about Copy of Newspaper Publication with respect to 33rd Annual General Meeting of the Company. The Company will hold its 33rd Annual General Meeting on September 21, 2026, through Video Conferencing or Other Audio Visual Means.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange regarding the allotment of 2,500 equity shares to eligible employees under the Bajaj Healthcare Limited Employee Stock Option Scheme 2024, upon the exercise of 2,500 vested stock options at an exercise price of ₹5/- per stock option.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about the allotment of 2,500 equity shares pursuant to the exercise of employee stock options under the Bajaj Healthcare Limited Employee Stock Option Scheme 2024.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has received approval from the Drug Controller General of India (DCGI) to manufacture and market Cenobamate API and Tablets in six strengths, marking a significant milestone in the Company's journey towards bringing advanced therapies to patients.
Bajaj Healthcare Limited
Bajaj Healthcare Limited's bank loan facilities have been upgraded to 'IND A' from 'IND A-' with a Stable Outlook, and short-term bank loan facilities have been upgraded to 'IND A1' from 'IND A2+', by India Ratings and Research (Ind-Ra).
Bajaj Healthcare Limited
Bajaj Healthcare Limited has announced the transcript of its Q1FY27 earnings call, highlighting its strategic focus on API and formulation businesses, including the expansion of its peptide manufacturing facility and the launch of new products such as Cenobamate Tablets and Posaconazole 300 mg tablet.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about the publication of Un-Audited Financial Results for the quarter ended June 30, 2026, in compliance with Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about the link of the recording of the earnings call for Q1FY27, which is available on the company's website.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange regarding the grant of 275 stock options to eligible employees under the Bajaj Healthcare Limited Employee Stock Option Plan 2024 at an exercise price of Rs. 5/- each.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue up 11.3% YoY, EBITDA up 16.4% YoY, and PAT up 15.8% YoY.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32, confirming no deviation or variation in the utilisation of proceeds raised through the allotment of Equity Shares.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended June 30, 2026, regarding the utilization of proceeds raised through the preferential issue of equity shares and conversion of warrants into equity shares.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about change in Management, continuation of directorship of Mr. Gopalakrishnan Kesavan as a Non-Executive Independent Director of the Company upon attaining the age of 75 years.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has submitted its unaudited standalone financial results for the quarter ended June 30, 2026, along with the Limited Review Report issued by Walker Chandiok & Co LLP, Chartered Accountants, Statutory Auditors of the Company.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has scheduled an earnings call to discuss its financial performance for Q1 FY27 on July 21, 2026, at 4:00 pm IST.
Bajaj Healthcare Limited
Bajaj Healthcare Limited has informed the Exchange about the schedule of its earnings call to discuss the financial performance for Q1 FY27.